Demographics and Baseline Characteristics, n=23
| Variable | Value |
|---|---|
| Age, years, mean (range) | 52.9 (38-80) |
| Male | 16 (69.6) |
| Black | 22 (95.7) |
| History of hypertension | 20 (87.0) |
| History of diabetes | 12 (52.2) |
| Obesity (BMI >30 kg/m2) | 12 (52.2) |
| History of malignancy | 3 (13.0) |
| Time posttransplant to admission, years, median (IQR) | 7 (10.6) |
| Type of transplant | |
| Kidney alone | 18 (78.3) |
| Kidney and pancreas | 3 (13.0) |
| Kidney and liver | 2 (8.7) |
| Maintenance immunosuppression | |
| Calcineurin inhibitor plus antiproliferative agenta | 18 (78.3) |
| Low-dose prednisone | 17 (73.9) |
| Chronic kidney disease stage | |
| 2 | 5 (21.7) |
| 3a | 8 (34.8) |
| 3b | 7 (30.4) |
| 4 | 3 (13.0) |
| Baseline serum creatinine, mg/dL, mean (range) | 1.8 (1.0-2.8) |
↵aCalcineurin inhibitors were either tacrolimus or cyclosporine. Antiproliferative agents were either mycophenolate mofetil or azathioprine.
Note: Data are presented as n (%) unless otherwise indicated.
BMI, body mass index.